|
Much of the recent AI hype train has centered around mesmerizing digital content generated from simple prompts, alongside concerns about its ability to decimate the workforce and make malicious propaganda much more convincing. (Fun!) However, some of AI's most promising — and potentially much less ominous — work lies in medicine. A new update to Google's AlphaFold software could lead to new disease research and treatment breakthroughs.
AlphaFold software, from Google DeepMind and (the also Alphabet-owned) Isomorphic Labs, has already demonstrated that it can predict how proteins fold with shocking accuracy. It's cataloged a staggering 200 million known proteins, and Google says millions of researchers have used previous versions to make discoveries in areas like malaria vaccines, cancer treatment and enzyme designs.
Knowing a protein's shape and structure determines how it interacts with the human body, allowing
|
|
An incredible new study has upended our understanding of genetic Alzheimer's disease, finding that nearly everyone carrying two copies of a culprit gene had distinct biological markers of the degenerative condition by the age of 65. This means the APOE4 gene may no longer merely a risk factor but the driver behind a new stand-alone genetic Alzheimer's disease type that could impact up to 10 million Americans and more than 200 million people worldwide.
Continue Reading
Medical, S
|
|